The National Coalition for LGBTQ Health’s Mpox Resource Center provides up-to-date information, data, and general news from public health authorities on mpox in the United States, including prevention, transmission, testing, and treatment. The Resource Center also houses digital and printable assets for use by clinicians and community members to promote awareness of mpox.
Find mpox vaccinations at your local health department with this locator from NACCHO.
Find mpox vaccinations at a nearby community health center with this locator from HRSA.
This National Coalition for LGBTQ Health on-demand webinar provides an in-depth look at current best practices on community responses to and education strategies regarding Mpox in the United States.
This webinar aims to highlight the work in protecting communities in the current mpox emergency and the evolving situation, including the specific needs of the different affected communities and how those can be addressed.
The National Coalition for LGBTQ Health has launched the “mfax” education and awareness campaign to raise awareness and provide education about mpox prevention, vaccination, testing, and treatment, as well as foster LGBTQ community engagement.
The Telegraph: The UK Health Security Agency has launched an investigation to determine how a person in North East England caught the virus.
Two vaccines can be used to prevent mpox: JYNNEOS® and ACAM2000®, but only JYNNEOS has been used in the ongoing clade II outbreak. Healthcare providers should evaluate and counsel patients who could benefit from mpox vaccination by performing a social and sexual history.
Archived update from the White House from December 2024. During the 2022 global outbreak of clade II mpox, the Biden-Harris Administration mounted a robust response by making vaccines, tests, and treatment available to those at risk in the United States and abroad.
On November 15, 2024, the California Department of Public Health (CDPH) confirmed the first reported case of clade I mpox in the United States. This individual had recently traveled to areas experiencing clade I monkeypox virus (MPXV) transmission and sought medical care for mpox symptoms in the United States.
The World Health Organization (WHO) today launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts. This follows the declaration of a public health emergency of international concern by the WHO Director-General on 14 August 2025.
These downloadable fact sheets from the CDC answer common questions about safer sex, social gatherings, and mpox.
Demetre Daskalakis, MD, MPH, Acting Director of the National Center for Immunization and Respiratory Diseases at the CDC, provides the latest on mpox in this FAQ series from KFF and CDC.
Communities can monitor the presence of mpox virus in wastewater samples. Data from samples can provide an early warning of mpox activity and spread in communities. This dashboard from the CDC displays the latest sample data.
To help meet domestic and international mpox response goals, CDC is urging clinicians to let patients with mpox know that oral tecovirimat is available through STOMP and encourage them to enroll. Providers should inform patients about STOMP so they can consider enrolling in the study.
Tecovirimat (TPOXX) and Guidance for Tecovirimat Use pages are now live.
This dashboard displays trends of mpox cases reported to CDC during the 2022 outbreak by date. As of May 1, 2024, U.S. mpox case trends data will be updated the first week of every month.
© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map
